BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.68 and traded as low as $0.47. BioCorRx shares last traded at $0.47, with a volume of 245 shares trading hands.
BioCorRx Stock Down 4.1 %
The stock has a market capitalization of $4.54 million, a PE ratio of -1.02 and a beta of 0.59. The stock has a fifty day moving average of $0.68 and a 200-day moving average of $0.83.
BioCorRx (OTCMKTS:BICX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.14) earnings per share (EPS) for the quarter.
BioCorRx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Stories
- Five stocks we like better than BioCorRx
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What is a Death Cross in Stocks?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How Investors Can Find the Best Cheap Dividend Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
